Cell line development for production of clinical grade HSV vectors.

被引：0
|
作者：
Grant, KG [1 ]
Ataai, MM [1 ]
Glorioso, JC [1 ]
Krisky, D [1 ]
机构：
[1] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15219 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
297-BIOT
引用
收藏
页码：U225 / U225
页数：1
相关论文
共 50 条
  • [21] Production of L-DOPA by genetic ally modified fibroblasts with retroviral vectors.
    Ishida, A
    Yamashiro, K
    Mukawa, J
    Hasegawa, M
    NEUROSCIENCES-JAPAN, 1995, 21 : P9 - P12
  • [22] DEVELOPMENT OF THE PRODUCT FORM ALGORITHM FOR THE SIMPLEX METHOD USING REDUCED TRANSFORMATION VECTORS.
    Powell, Susan
    Mathematical Programming Study, 1975, (04): : 92 - 107
  • [23] A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration
    R Loew
    Y Meyer
    K Kuehlcke
    L Gama-Norton
    D Wirth
    H Hauser
    S Stein
    M Grez
    S Thornhill
    A Thrasher
    C Baum
    A Schambach
    Gene Therapy, 2010, 17 : 272 - 280
  • [24] A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration
    Loew, R.
    Meyer, Y.
    Kuehlcke, K.
    Gama-Norton, L.
    Wirth, D.
    Hauser, H.
    Stein, S.
    Grez, M.
    Thornhill, S.
    Thrasher, A.
    Baum, C.
    Schambach, A.
    GENE THERAPY, 2010, 17 (02) : 272 - 280
  • [25] Process Development of Lentiviral Vectors for Large Scale Production Using a HEK293 Producer Cell Line
    Audy, Alexandre
    Robert, Marc-Andre
    Chahal, Parminder
    Gilbert, Renald
    Gaillet, Bruno
    MOLECULAR THERAPY, 2016, 24 : S279 - S280
  • [26] Development of a stable, inducible (N-1) cell line for the efficient and high titer production of lentiviral vectors
    George, H.
    George, H.
    Pegg, L.
    Spencer, A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A103 - A103
  • [27] Stable packaging cell lines development for the production of lentiviral vectors
    Broussau, S
    Jabbour, N
    Lachapelle, G
    Xu, Y
    Mullick, A
    Gilbert, R
    Bernard, M
    MOLECULAR THERAPY, 2004, 9 : S29 - S29
  • [28] DEVELOPMENT AND TESTING OF A PACKAGING CELL-LINE FOR AVIAN RETROVIRAL VECTORS
    MEYERS, NL
    BOOTH, SC
    BUMSTEAD, N
    VICK, L
    SIMKISS, K
    ARCHIVES OF VIROLOGY, 1991, 119 (3-4) : 257 - 264
  • [29] Recent advances in the development of oncolytic HSV-1 vectors: 'Arming' of HSV-1 vectors and application of bacterial artificial chromosome
    Jeyaretna, Deva S.
    Kuroda, Toshihiko
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (05) : 447 - 466
  • [30] Effects of culture parameters on the production of retroviral vectors by a human packaging cell line
    McTaggart, S
    Al-Rubeai, M
    BIOTECHNOLOGY PROGRESS, 2000, 16 (05) : 859 - 865
12345